AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇼

RITUXIMAB in Zimbabwe

3 products registered with MCAZ — 3 active

Brand / ProductReg. No.HolderStatusExpires
MABTHERA 500
INJECTABLE; INJECTION
2016/9.7/5176ROCHE PRODUCTSactive31 Dec 2027
MABTHERA 100
SOLUTION; INFUSION
2016/9.7/5175ROCHE PRODUCTSactive31 Dec 2027
MABTHERA SC 1400
INJECTABLE; INJECTION
2017/9.7/5511ROCHE PRODUCTS (PTY) LTDactive31 Dec 2027

RITUXIMAB — MCAZ Registration Details

MCAZ (Zimbabwe) has 3 registered products containing RITUXIMAB, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.